BE859067A - Nouveaux amino-ethers peptidiques, leur preparation et leur application comme medicaments - Google Patents

Nouveaux amino-ethers peptidiques, leur preparation et leur application comme medicaments

Info

Publication number
BE859067A
BE859067A BE181214A BE181214A BE859067A BE 859067 A BE859067 A BE 859067A BE 181214 A BE181214 A BE 181214A BE 181214 A BE181214 A BE 181214A BE 859067 A BE859067 A BE 859067A
Authority
BE
Belgium
Prior art keywords
ethers
preparation
application
medicinal products
peptidic amino
Prior art date
Application number
BE181214A
Other languages
English (en)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of BE859067A publication Critical patent/BE859067A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BE181214A 1976-09-28 1977-09-26 Nouveaux amino-ethers peptidiques, leur preparation et leur application comme medicaments BE859067A (fr)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
CH1224776 1976-09-28
CH1244976 1976-10-01
CH1245076 1976-10-01
CH1294276 1976-10-13
CH1294176 1976-10-13
CH1357476 1976-10-28
CH161677 1977-02-10
CH161577 1977-02-10
CH206077 1977-02-18

Publications (1)

Publication Number Publication Date
BE859067A true BE859067A (fr) 1978-03-28

Family

ID=27575767

Family Applications (1)

Application Number Title Priority Date Filing Date
BE181214A BE859067A (fr) 1976-09-28 1977-09-26 Nouveaux amino-ethers peptidiques, leur preparation et leur application comme medicaments

Country Status (7)

Country Link
JP (1) JPS5356684A (fr)
AU (1) AU2912777A (fr)
BE (1) BE859067A (fr)
DE (1) DE2742435A1 (fr)
FR (1) FR2365554A1 (fr)
IL (1) IL53000A0 (fr)
NL (1) NL7710418A (fr)

Cited By (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4287120A (en) * 1979-12-13 1981-09-01 Eli Lilly And Company Derivatives of S31794/F-1 nucleus
US4289692A (en) * 1979-12-13 1981-09-15 Eli Lilly And Company Derivatives of A-30912D nucleus
US4293486A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of S31794/F-1 nucleus
US4293484A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912H nucleus
US4293490A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company A-30912H Nuclei
US4293487A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912D nucleus
US4293488A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912B nucleus
US4293491A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912H nucleus
US4293489A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912A nucleus
US4293482A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company A-30912A Nucleus
US4293485A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of S31794/F-1 nucleus
US4293483A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912A nucleus
US4297277A (en) * 1979-12-13 1981-10-27 Eli Lilly And Company Derivatives of A-30912B nucleus
US4299762A (en) * 1979-12-13 1981-11-10 Eli Lilly And Company A-30912D Nucleus
US4299763A (en) * 1979-12-13 1981-11-10 Eli Lilly And Company A-30912B Nucleus
US4304716A (en) * 1979-12-13 1981-12-08 Eli Lilly And Company S 31794/F-1 Nucleus
US4320052A (en) * 1979-12-13 1982-03-16 Eli Lilly And Company Derivatives of A-30912A nucleus
US4320053A (en) * 1979-12-13 1982-03-16 Eli Lilly And Company Derivatives of A-30912D nucleus
US4320054A (en) * 1979-12-13 1982-03-16 Eli Lilly And Company Derivatives of A-30912H nucleus
US4322338A (en) * 1979-12-13 1982-03-30 Eli Lilly And Company Derivatives of A-30912B nucleus
US5021341A (en) * 1990-03-12 1991-06-04 Merck & Co., Inc. Antibiotic agent produced by the cultivation of Zalerion microorganism in the presence of mannitol
US5021403A (en) * 1990-03-19 1991-06-04 Merck & Co., Inc. Antibiotic agents
US5049546A (en) * 1990-03-19 1991-09-17 Merck & Co., Inc. Antibiotic agents
US5166135A (en) * 1988-09-12 1992-11-24 Merck & Company, Inc. Method for the control of pneumocystis carinii
WO1994009033A1 (fr) * 1992-10-16 1994-04-28 Merck & Co., Inc. Procede ameliore de preparation de composes de bisamine cyclohexapeptidyle
WO1994025048A1 (fr) * 1993-04-30 1994-11-10 Merck & Co., Inc. Composes amine cyclohexapeptidyle
US5399552A (en) * 1991-10-17 1995-03-21 Merck & Co, Inc Antibiotic peptides bearing aminoalkylthioether moieties
WO1995008341A1 (fr) * 1993-09-22 1995-03-30 Merck & Co., Inc. Composes antifongiques et anti-pneumocystose, compositions les contenant et procedes d'utilisation
US5514650A (en) * 1993-03-16 1996-05-07 Merck & Co., Inc. Aza cyclohexapeptide compounds
US5646245A (en) * 1994-08-23 1997-07-08 Balkovec; James M. Process for preparing side chain derivatives of cyclohexapeptidyl lipopeptides
US5741775A (en) * 1993-05-04 1998-04-21 Merck & Co., Inc. Cyclohexapeptidyl aminoalkyl ethers
US5874403A (en) * 1992-10-15 1999-02-23 Merck & Co., Inc. Amino acid conjugates of cyclohexapeptidyl amines
US5914313A (en) * 1991-10-17 1999-06-22 Merck & Co., Inc. 1- 4-hydroxy-5-aminoethyloxy-N2 -(10,12-dimethyl-1-oxotetradecyl)ornithine!-5-(3-hydroxyglutamine)-6-(3-hydroxyproline)echinocandin B, other aminoalkyl derivatives and salts thereof
US5939384A (en) * 1991-10-01 1999-08-17 Merck & Co., Inc. Cyclohexapeptidyl propanolamine compounds
US5948753A (en) * 1993-05-04 1999-09-07 Merck & Co., Inc. Cyclohexapeptidyl propanolamine compounds
US6030944A (en) * 1991-10-01 2000-02-29 Merck & Co., Inc. Cyclohexapeptidyl bisamine compounds

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2458551A1 (fr) * 1979-06-08 1981-01-02 Lilly Co Eli Nouveaux antibiotiques, leur preparation et leur utilisation
FR2476074A1 (fr) * 1979-12-13 1981-08-21 Lilly Co Eli Derives de noyaux peptidiques cycliques, leur preparation et leur utilisation comme agents antifongiques
CA1170598A (fr) * 1979-12-13 1984-07-10 Bernard J. Abbott Methode de preparation de noyaux peptidiques cycliques
CA1182812A (fr) * 1979-12-13 1985-02-19 Bernard J. Abbott Preparation de derives de noyaux de peptides cycliques
US5516757A (en) * 1994-09-16 1996-05-14 Merck & Co., Inc. Semi-synthetic lipopeptides, compositions containing said lipopeptides, and methods of use
US5516756A (en) * 1994-10-31 1996-05-14 Merck & Co., Inc. Aza cyclohexapeptide compounds
WO1996022784A1 (fr) * 1995-01-26 1996-08-01 Merck & Co., Inc. Nouveaux cyclohexapeptides antifongiques
WO2016201283A1 (fr) 2015-06-12 2016-12-15 Cidara Therapeutics, Inc. Agents antifongiques

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2704030A1 (de) * 1976-02-12 1977-08-18 Sandoz Ag Neue organische verbindungen, ihre herstellung und verwendung

Cited By (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4320054A (en) * 1979-12-13 1982-03-16 Eli Lilly And Company Derivatives of A-30912H nucleus
US4320052A (en) * 1979-12-13 1982-03-16 Eli Lilly And Company Derivatives of A-30912A nucleus
US4293486A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of S31794/F-1 nucleus
US4293484A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912H nucleus
US4293490A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company A-30912H Nuclei
US4293487A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912D nucleus
US4293488A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912B nucleus
US4293491A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912H nucleus
US4293489A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912A nucleus
US4293482A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company A-30912A Nucleus
US4293485A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of S31794/F-1 nucleus
US4293483A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912A nucleus
US4297277A (en) * 1979-12-13 1981-10-27 Eli Lilly And Company Derivatives of A-30912B nucleus
US4299762A (en) * 1979-12-13 1981-11-10 Eli Lilly And Company A-30912D Nucleus
US4299763A (en) * 1979-12-13 1981-11-10 Eli Lilly And Company A-30912B Nucleus
US4304716A (en) * 1979-12-13 1981-12-08 Eli Lilly And Company S 31794/F-1 Nucleus
US4322338A (en) * 1979-12-13 1982-03-30 Eli Lilly And Company Derivatives of A-30912B nucleus
US4320053A (en) * 1979-12-13 1982-03-16 Eli Lilly And Company Derivatives of A-30912D nucleus
US4289692A (en) * 1979-12-13 1981-09-15 Eli Lilly And Company Derivatives of A-30912D nucleus
US4287120A (en) * 1979-12-13 1981-09-01 Eli Lilly And Company Derivatives of S31794/F-1 nucleus
US5166135A (en) * 1988-09-12 1992-11-24 Merck & Company, Inc. Method for the control of pneumocystis carinii
US5021341A (en) * 1990-03-12 1991-06-04 Merck & Co., Inc. Antibiotic agent produced by the cultivation of Zalerion microorganism in the presence of mannitol
US5021403A (en) * 1990-03-19 1991-06-04 Merck & Co., Inc. Antibiotic agents
US5049546A (en) * 1990-03-19 1991-09-17 Merck & Co., Inc. Antibiotic agents
US6030944A (en) * 1991-10-01 2000-02-29 Merck & Co., Inc. Cyclohexapeptidyl bisamine compounds
US5939384A (en) * 1991-10-01 1999-08-17 Merck & Co., Inc. Cyclohexapeptidyl propanolamine compounds
US5399552A (en) * 1991-10-17 1995-03-21 Merck & Co, Inc Antibiotic peptides bearing aminoalkylthioether moieties
US5914313A (en) * 1991-10-17 1999-06-22 Merck & Co., Inc. 1- 4-hydroxy-5-aminoethyloxy-N2 -(10,12-dimethyl-1-oxotetradecyl)ornithine!-5-(3-hydroxyglutamine)-6-(3-hydroxyproline)echinocandin B, other aminoalkyl derivatives and salts thereof
US5874403A (en) * 1992-10-15 1999-02-23 Merck & Co., Inc. Amino acid conjugates of cyclohexapeptidyl amines
WO1994009033A1 (fr) * 1992-10-16 1994-04-28 Merck & Co., Inc. Procede ameliore de preparation de composes de bisamine cyclohexapeptidyle
US5792746A (en) * 1993-03-16 1998-08-11 Merck & Co., Inc. Aza cyclohexapeptide compounds
US5514650A (en) * 1993-03-16 1996-05-07 Merck & Co., Inc. Aza cyclohexapeptide compounds
WO1994025048A1 (fr) * 1993-04-30 1994-11-10 Merck & Co., Inc. Composes amine cyclohexapeptidyle
US6268338B1 (en) 1993-04-30 2001-07-31 Merck & Co., Inc. Cyclohexapeptidyl amine compounds
US5741775A (en) * 1993-05-04 1998-04-21 Merck & Co., Inc. Cyclohexapeptidyl aminoalkyl ethers
US5948753A (en) * 1993-05-04 1999-09-07 Merck & Co., Inc. Cyclohexapeptidyl propanolamine compounds
WO1995008341A1 (fr) * 1993-09-22 1995-03-30 Merck & Co., Inc. Composes antifongiques et anti-pneumocystose, compositions les contenant et procedes d'utilisation
US5684128A (en) * 1994-08-23 1997-11-04 Merck & Co., Inc. Process for preparing side chain derivatives of cyclohexapeptidyl lipopeptides
US5646245A (en) * 1994-08-23 1997-07-08 Balkovec; James M. Process for preparing side chain derivatives of cyclohexapeptidyl lipopeptides

Also Published As

Publication number Publication date
FR2365554A1 (fr) 1978-04-21
JPS5356684A (en) 1978-05-23
DE2742435A1 (de) 1978-04-06
IL53000A0 (en) 1977-11-30
NL7710418A (nl) 1978-03-30
AU2912777A (en) 1979-04-05

Similar Documents

Publication Publication Date Title
BE859067A (fr) Nouveaux amino-ethers peptidiques, leur preparation et leur application comme medicaments
BE838509A (fr) Nouveaux derives de l'isoxazole, leur preparation et leur application comme medicaments
FR2349566A1 (fr) Nouvelles (1-naphtylalkyl)-amines, leur preparation et leur application comme medicaments
BE865165A (fr) Nouveaux 1-amino-indanes et leur utilisation comme medicaments
BE884075A (fr) Nouveaux dipeptides, leur preparation et les medicaments qui les contiennent
FR2339590A1 (fr) Nouveaux composes polypeptidiques, leur preparation et leur application comme medicaments
BE860613A (fr) Nouveaux derives de la morphanthridine, leur preparation et leur application comme medicaments
FR2303560A1 (fr) Nouveaux polypeptides, leur preparation et leur application comme medicaments
FR2333504A1 (fr) Nouveaux derives de l'indazole, leur preparation et leur application comme medicaments
BE873658A (fr) Nouveaux derives de la guanidine, leur preparation et leur application comme medicaments
BE839967R (fr) Nouveaux derives de l'isoquinoleine, leur preparation et leur application comme medicaments
BE874683A (fr) Nouveaux derives bicyclo-octaniques leur preparation et leur utilisation comme medicaments
FR2339598A1 (fr) Nouveaux derives de la pyrrolidine, leur preparation et leur application comme medicaments
BE867121A (fr) Nouveaux composes polypeptidiques, leur preparation et leur application comme medicaments
BE884076A (fr) Nouveaux tripeptides, leur preparation et les medicaments qui les contiennent
FR2275200A1 (fr) Nouveaux composes heterocycliques, leur preparation et leur application comme medicaments
BE856899A (fr) Nouveaux composes polypeptidiques, leur preparation et leur application comme medicaments
FR2342065A1 (fr) Nouveaux composes heterocycliques, leur preparation et leur application comme medicaments
FR2316949A1 (fr) Derives du benzo-cyclohepta-thiophene, leur preparation et leur application comme medicaments
BE858887A (fr) Nouveaux perhydro-indolinols, leur preparation et leur application comme medicaments
BE839969A (fr) Nouveaux derives de l'isoquinoleine, leur preparation et leur application comme medicaments
BE867339A (fr) Nouveaux derives de la 5-phenyl-1h-3-benzazepine, leur preparation et leur utilisation comme medicaments
BE862038A (fr) 1-amino-alkyl inferieur-3,4-diphenyl-1h-pyrazoles et leur utilisation comme medicaments
LU78914A1 (fr) Nouvelles arylenedioxy-bis-dicetones,leur preparation et leur utilisation comme medicaments
FR2322594A1 (fr) Nouvelles 2,3-trans-methylene-15-hydroxy-prostaglandines, leur preparation et leur application comme medicaments